Product Information

PREGABALIN 300 MG CAPSULE is a generic product labeled by Westminster Pharmaceuticals LLC, priced at $0.0644 per EA under NDC 69367033109. Its NADAC has been published 255 times since Oct 6, 2021.

FDA first approved this application on Jul 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PREGABALIN 300 MG CAPSULE

Pregabalin
$0.0644per EA
DEA Schedule CV

Strength

300 mg/1

NDC

69367033109

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA208677

FDA Approved

7/19/2019

TE Code

AB

On Market Since

8/24/2021

Price Statistics

The NADAC for PREGABALIN 300 MG CAPSULE has been published 255 times since Oct 6, 2021, and over the history we have for it it has declined 50.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0644 per EA
All-time high$0.1301 (Oct 13, 2021)
All-time low$0.0628 (Nov 20, 2024)
52-week high$0.0784
52-week low$0.0644
Median price$0.0884
Average price$0.0898
Largest weekly change+30.8% (Aug 21, 2024)
Weeks tracked255
Tracking sinceOct 6, 2021

Price History

1W

-0.2%

1M

-2.2%

3M

-1.3%

6M

-3.8%

1Y

-19.5%

3Y

-32.4%

5Y

N/A

All

-50.5%

Generic Alternatives

The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of PREGABALIN 300 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 300 MG CAPSULE, manufactured by Westminster Pharmaceuticals LLC, is $0.0644 per EA (NDC 69367033109), effective Aug 19, 2026.

How has the price of PREGABALIN 300 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PREGABALIN 300 MG CAPSULE has declined 50.5%. It has been tracked across 255 weekly CMS publications since Oct 6, 2021.

What are the highest and lowest recorded NADAC prices for PREGABALIN 300 MG CAPSULE?

Since Oct 6, 2021, the NADAC for PREGABALIN 300 MG CAPSULE has ranged from a low of $0.0628 (Nov 20, 2024) to a high of $0.1301 (Oct 13, 2021), with a median of $0.0884 per EA.

Are there cheaper alternatives to PREGABALIN 300 MG CAPSULE?

10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PREGABALIN 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures PREGABALIN 300 MG CAPSULE?

PREGABALIN 300 MG CAPSULE (NDC 69367033109) is labeled by Westminster Pharmaceuticals LLC, and CMS classifies it as a generic product.